Aphria Announces Closing of Bought Deal Financing

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH) is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 8,846,370 units (the "Units") of the Company were sold at a price of $1.30 per Unit, for aggregate gross proceeds of $11,500,281 (the "Offering"). Each Unit consisted of one common share of the Company (a "Unit Share") and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one common share of the Company (a "Warrant Share") at a price of $1.75 until December 11, 2018. The Offering was underwritten by a syndicate of underwriters co-led by Clarus Securities Inc. and GMP Securities L.P.

The net proceeds from the Offering are expected to be used for future expansion...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.